DOI QR코드

DOI QR Code

Overlap myositis associated with Sjögren's syndrome

  • Eun Ji Lee (Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine) ;
  • Rae On Kim (Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine) ;
  • Yon Hee Kim (Department of Pathology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine) ;
  • Hakjae Roh (Department of Neurology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine)
  • Received : 2022.09.19
  • Accepted : 2022.11.11
  • Published : 2023.04.30

Abstract

Overlap myositis (OM) associated with Sjögrens syndrome (SS) is a relatively uncommon disorder. It is more difficult to detect OM when a patient had not been previously diagnosed with SS. We report a case of OM associated SS that initially presented with dysphagia followed by proximal weakness. If proximal muscle weakness is preceded by dysphagia, the possibility of OM associated with connective-tissue disease should be considered.

Keywords

Acknowledgement

This research was supported by the Soonchunhyang University Research Fund.

References

  1. Nuno-Nuno L, Joven BE, Carreira PE, Maldonado-Romero V, Larena-Grijalba C, Llorente Cubas I, et al. Overlap myositis, a distinct entity beyond primary inflammatory myositis: a retrospective analysis of a large cohort from the REMICAM registry. Int J Rheum Dis 2019;22:1393-1401. https://doi.org/10.1111/1756-185X.13559
  2. Maundrell A, Proudman S, Limaye V. Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies. Rheumatol Int 2019;39:1777-1781. https://doi.org/10.1007/s00296-019-04411-8
  3. Jung SH, Lee KJ, Hong JB, Han TR. Validation of clinical dysphagia scale: based on videofluoroscopic swallowing study. J Korean Acad Rehabil Med 2005;29:343-350.
  4. Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc 2007;82:441-447. https://doi.org/10.4065/82.4.441
  5. Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, et al. The euromyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 2018;77:30-39. https://doi.org/10.1136/annrheumdis-2017-211868
  6. Stathopoulos P, Dalakas MC. Autoimmune neurogenic dysphagia. Dysphagia 2022;37:473-487. https://doi.org/10.1007/s00455-021-10338-9
  7. Labeit B, Pawlitzki M, Ruck T, Muhle P, Claus I, Suntrup-Krueger S, et al. The impact of dysphagia in myositis: a systematic review and meta-analysis. J Clin Med 2020;9:2150.
  8. Galindo-Feria AS, Rojas-Serrano J, Hinojosa-Azaola A. Clinical and prognostic factors associated with survival in Mexican patients with idiopathic inflammatory myopathies. J Clin Rheumatol 2016;22:51-56. https://doi.org/10.1097/RHU.0000000000000365
  9. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European league against rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017;69:35-45. https://doi.org/10.1002/art.39859
  10. Senecal JL, Raynauld JP, Troyanov Y. Editorial: a new classification of adult autoimmune myositis. Arthritis Rheumatol 2017;69:878-884 https://doi.org/10.1002/art.40063